Chromium contents, distribution and bioaccessibility in cultivated mushrooms from market: Health implications for human consumption

Mushrooms are consumed worldwide as they constitute a part of traditional cuisine culture in many countries. However, chromium (Cr) accumulation in mushrooms may constitute a potential pathway for its chronical exposure to humans. In this work, the Cr contents, distribution and bioaccessibility in 140 cultivated mushrooms from 14 species in 10 top-producing provinces in China were examined. Total Cr contents were 0.09-4.71 mg center dot kg 1 dw (mean 0.74 mg kg 1), with 59% exceeding the 0.5 mg kg 1standard. Additionally, less Cr was accumulated in the caps than stipes, with Cr ratio in caps/stipes being 0.28-2.6, averaging 0.91. Based on the Solubility Bioaccessibility Research Consortium (SBRC) assay, the mean Cr bioaccessibility in the mushrooms was 24.8% and 50.1% in the gastric phase (GP) and intestinal phase (IP). However, samples from Guizhou show the lowest Cr bioaccessibility at 12.5% in GP and 24.8% in IP. Further, a negative correlation between total Cr contents and Cr bioaccessibility suggests that Cr bioaccessibility is critical for accurate assessment of Cr exposure. In addition, drying mushrooms increased their bioaccessibility in the gastric phase. This study shows a high Cr exceeding rate of cultivated mushrooms, which may indicate a potential exposure risk, with Cr contents and bioaccessibility showing species and regional variation.